Re: Tweet from Prof Kausik Ray
posted on
Jun 02, 2020 09:42AM
IMO, premature for a Phase 4. Apabetalone is not approved for any indication yet and has failed to meet the primary endpoint in its past 2 major trials (Phase 2 ASSURE, Phase 3 BETonMACE).
BDAZ